Balance Sheet
Accounts PayablesAssetsCash & EquivalentsConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Retained Earnings: 2022-2024

Historic Retained Earnings for Abivax (ABVX) over the last 3 years, with Dec 2024 value amounting to -$284.3 million.

  • Abivax's Retained Earnings fell 65.66% to -$484.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$484.3 million, marking a year-over-year decrease of 65.66%. This contributed to the annual value of -$284.3 million for FY2024, which is 77.87% down from last year.
  • According to the latest figures from FY2024, Abivax's Retained Earnings is -$284.3 million, which was down 77.87% from -$159.8 million recorded in FY2023.
  • Abivax's 5-year Retained Earnings high stood at -$87.2 million for FY2022, and its period low was -$284.3 million during FY2024.
  • For the 3-year period, Abivax's Retained Earnings averaged around -$177.1 million, with its median value being -$159.8 million (2023).
  • Data for Abivax's Retained Earnings shows a maximum YoY crashed of 83.20% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Abivax's Retained Earnings stood at -$87.2 million in 2022, then crashed by 83.20% to -$159.8 million in 2023, then plummeted by 77.87% to -$284.3 million in 2024.